Literature DB >> 12807873

A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling.

Ruey-Bing Yang1, Chi Kin Domingos Ng, Scott M Wasserman, László G Kömüves, Mary E Gerritsen, James N Topper.   

Abstract

We have previously utilized a combination of high throughput sequencing and genome-wide microarray profiling analyses to identify novel cell-surface proteins expressed in human umbilical vein endothelial cells. One gene identified by this approach encodes a type I transmembrane receptor that shares sequence homology with the intracellular domain of members of the interleukin-17 (IL-17) receptor family. Real-time quantitative PCR and Northern analyses revealed that this gene is highly expressed in human umbilical vein endothelial cells and in several highly vascularized tissues such as kidney, colon, skeletal muscle, heart, and small intestine. In addition, we also found that it is also highly expressed in the ductal epithelial cells of human salivary glands, seminal vesicles, and the collecting tubules of the kidney by in situ hybridization. This putative receptor, which we have termed human SEF (hSEF), is also expressed in a variety of breast cancer tissues. In co-immunoprecipitation assays, this receptor is capable of forming homomeric complexes and can interact with fibroblast growth factor (FGF) receptor 1. Overexpression of this receptor inhibits FGF induction of an FGF-responsive reporter gene in human 293T cells. This appears to occur as a result of specific inhibition of p42/p44 ERK in the absence of upstream MEK inhibition. This inhibitory effect is dependent upon a functional intracellular domain since deletion mutants missing the IL-17 receptor-like domain lack this inhibitory effect. These findings are consistent with the recent discovery of the zebrafish homologue, Sef (similar expression to fgf genes), which specifically antagonizes FGF signaling when ectopically expressed in zebrafish or Xenopus laevis embryos. Based on sequence and functional similarities, this novel IL-17 receptor homologue represents a potential human SEF and is likely to play critical roles in endothelial or epithelial functions such as proliferation, migration, and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807873     DOI: 10.1074/jbc.M305022200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  IL-17 contributes to angiogenesis in rheumatoid arthritis.

Authors:  Sarah R Pickens; Michael V Volin; Arthur M Mandelin; Jay K Kolls; Richard M Pope; Shiva Shahrara
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

2.  Evidence for ligand-independent multimerization of the IL-17 receptor.

Authors:  Jill M Kramer; Ling Yi; Fang Shen; Amarnath Maitra; Xuanmao Jiao; Tian Jin; Sarah L Gaffen
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

Review 3.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

Review 4.  The IL-17 family cytokines in immunity and disease.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Naruhisa Ota; Wenjun Ouyang; Yan Hu
Journal:  J Clin Immunol       Date:  2010-02-23       Impact factor: 8.317

Review 5.  The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases.

Authors:  Rajita Pappu; Vladimir Ramirez-Carrozzi; Arivazhagan Sambandam
Journal:  Immunology       Date:  2011-07-04       Impact factor: 7.397

Review 6.  Fibroblast growth factor signaling in the vasculature.

Authors:  Xuehui Yang; Lucy Liaw; Igor Prudovsky; Peter C Brooks; Calvin Vary; Leif Oxburgh; Robert Friesel
Journal:  Curr Atheroscler Rep       Date:  2015-06       Impact factor: 5.113

7.  SCUBE3 (signal peptide-CUB-EGF domain-containing protein 3) modulates fibroblast growth factor signaling during fast muscle development.

Authors:  Cheng-Fen Tu; Ku-Chi Tsao; Shyh-Jye Lee; Ruey-Bing Yang
Journal:  J Biol Chem       Date:  2014-05-21       Impact factor: 5.157

8.  IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling.

Authors:  Zhili Rong; Anan Wang; Zhiyong Li; Yongming Ren; Long Cheng; Yinghua Li; Yinyin Wang; Fangli Ren; Xiaoning Zhang; Jim Hu; Zhijie Chang
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

9.  Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.

Authors:  Qing He; Yan Gong; Lindsey Gower; Xuehui Yang; Robert E Friesel
Journal:  J Cell Biochem       Date:  2016-03-16       Impact factor: 4.429

10.  Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.

Authors:  S Darby; T Murphy; H Thomas; C N Robson; H Y Leung; M E Mathers; V J Gnanapragasam
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.